Francesca L.
- Country
- Italy
- Department
- Nefrologia e Trapianto Rene
Research Overview
- Evaluation of Pegcetacoplan for Reducing Proteinuria in Adults and Adolescents with Focal Segmental Glomerulosclerosis
- Evaluation of Sparsentan in Pediatric Patients with Proteinuric Glomerular Diseases: A Phase 2, Open-Label, Single-Arm Cohort Study
- (22419) A randomized, double-blind, placebo-controlled, parallel group Phase 2a study with an extension phase to evaluate the efficacy and safety of BAY 3401016 in participants aged 18 to 45 with Alport syndrome
Data & Insights
Has run more than one trial at 7 of 60 partner sites.
Specializations
Renal Disease Expertise
The investigator specializes in the study and treatment of proteinuric glomerular diseases, with particular emphasis on pediatric kidney conditions. Their research focuses on innovative therapeutic approaches for various renal disorders.
- Focal segmental glomerulosclerosis (FSGS)
- Minimal change disease (MCD)
- IgA nephropathy
Pediatric Nephrology
The investigator demonstrates extensive experience in treating pediatric kidney diseases, particularly focusing on conditions affecting the glomerular filtration system. Their work encompasses the evaluation of novel therapeutic agents in young patients.
- Immunoglobulin A vasculitis
- Alport syndrome
- Proteinuria management
Clinical Assessment
The investigator's expertise extends to evaluating drug safety and tolerability in pediatric populations. Their research includes long-term assessment of therapeutic interventions for chronic kidney conditions.
- Drug pharmacokinetics
- Therapeutic efficacy assessment
- Long-term safety monitoring
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.